Please upgrade your browser.
Unfortunately, for renal cell carcinoma (RCC), early detection is almost impossible. At least 40 per cent of the patients are at an advanced stage of the disease when they are diagnosed.
Good response to second-line bevacizumab and interferon-[alpha] in a sunitinib-refractory patient with metastatic renal cell carcinoma
In clinical practice, sunitinib and bevacizumab are reserved for firstline treatment, but despite various guidelines, optimal treatment is still uncertain. The authors present, for the first time, a case of a good response to secondline bevacizumab and interferonalpha in a patient who failed classical sunitinib treatment.
Co-administration of cG250 and IL-2 or IFN-.alpha. for treating cancer such as renal cell carcinomas
A method for enhancing the therapeutic effect of cytokine treatment is disclosed. More specifically the present invention relates to a method for administering to a tumor patient a therapeutic dose of cytokine in combination with antibodies directed against the tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN).
What is a kidney cyst and should I worry about kidney cancer? Should I have this cyst removed?
The latest news related to kidney cancer, courtesy of the Kidney Cancer Association's electronic news clipping service.
Papillary renal cell carcinoma may display some unusual morphologic variations, including diffuse oncocytic change not otherwise specified, oncocytic change associated with an inverted nuclear pattern or nonoverlapping low-grade nuclei, low-grade spindle cells, and diffuse clear cells.
Educating the public, residents and referring physicians about radiation exposure and associated risk took a step forward with the creation of the new iPhone application, Radiation Passport.
Patients with advanced renal cell carcinoma who responded to angiogenesis inhibitor drugs also had higher hemoglobin levels, a researcher reported in a poster at the ASH 51st Annual Meeting, in New Orleans, Louisiana.
Kidney Cancer News is our periodical for patients, survivors, and others with an interest in kidney cancer. Subscribe here. If you are a registered user on this website, you'll receive this publication automatically. If not, click "Subscribe here" to create an account. FREE registration brings many benefits, including access to our online Forum for survivors and their families--more than 3,000 members strong, much bigger than any email listserve, and the largest virtual community of its kind!
|Powered by NeonCRM|